Reference
Yasuda M, et al. Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment. European Journal of Dermatology 29: 81-82, No. 1, Jan-Feb 2019. Available from: URL: https://www.jle.com/fr/revues/ejd/e-docs/concurrent_development_of_psoriatic_arthritis_drug_induced_interstitial_pneumonia_and_increased_anti_nuclear_antibodies_in_a_patient_with_psoriasis_vulgaris_undergoing_adalimumab_treatment_313298/article.phtml - Japan
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1755, 14 (2019). https://doi.org/10.1007/s40278-019-62568-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-62568-7